Imaging tools to visualize immune response
Latest News
July 12th, 2023
CellSight's collaborative work with UCSF and Stanford that highlights [18F]F-AraG's potential in cardiovascular imaging won 2nd place in the Cardiovascular track at SNNMI 2023 in Chicago.
February 1, 2022
Immunooncology Symposium, Center for Translation Cancer Research, Western University. "Towards in vivo Immunoscore: Assessing Systemic Immune Response with [18F]F-AraG".
November 14, 2021
SITC 2021 poster presentation. AI-assisted whole-body assessment of immunotherapy response using [18F]F-AraG, a PET agent for activated T cells.
October 5th, 2021
WMIC Spotlight Session presentation. The other ImmunoPET: Visualizing T cell Activity with [18F]F-AraG.
April 9, 2021
UCSF researchers publish "Longitudinal imaging of T-cells and inflammatory demyelination in a preclinical model of multiple sclerosis using [18F]F-AraG PET and MRI" in Journal of Nuclear Medicine
November 11, 2020
"[18F]F-AraG PET for CD8 Profiling of Tumors and Assessment of Immunomodulation by Chemotherapy" published in Journal of Nuclear Medicine
May 7, 2019
"Imaging of activated T cells as an early predictor of immune response to anti-PD-1 therapy" published in Cancer Research